Table 1.
# | Species | Sex | Age at death (yrs) | Method of fixation | Strain | Genotype | EP1536Y staining* | TBX21 staining† | Disease |
---|---|---|---|---|---|---|---|---|---|
1 | Mus musculus | M | 0.66 | PF/DF | C57BL/6 J | α-syn KO | 0 | 1 | NA |
2 | Mus musculus | M | 0.66 | PF/DF | C57BL/6 J | α-syn KO | 0 | 1 | NA |
3 | Mus musculus | M | 0.66 | PF/DF | C57BL/6 J | α-syn KO | 0 | 1 | NA |
4 | Mus musculus | M | 0.66 | PF/DF | C57BL/6 J | α-syn KO | 0 | 1 | NA |
5 | Mus musculus | M | 0.66 | PF/DF | C57BL/6 J | WT | 1 | 1 | NA |
6 | Mus musculus | M | 0.66 | PF/DF | C57BL/6 J | WT | 1 | 1 | NA |
7 | Mus musculus | M | 0.66 | PF/DF | C57BL/6 J | WT | 0 | 1 | NA |
8 | Mus musculus | M | 0.66 | PF/DF | C57BL/6 J | WT | 1 | 1 | NA |
9 | Mus musculus | M | 0.83 | PF/DF | C57BL/6 J | WT | 1 | ND | NA |
10 | Mus musculus | M | 0.83 | PF/DF | C57BL/6 J | WT | 1 | ND | NA |
11 | Mus musculus | M | 0.83 | PF/DF | C57BL/6 J | WT | 1 | ND | NA |
12 | Mus musculus | F | 0.66 | PF/DF | C57BL/6 J | α-syn KO | 0 | 1 | NA |
13 | Mus musculus | F | 0.66 | PF/DF | C57BL/6 J | α-syn KO | 0 | 1 | NA |
14 | Mus musculus | F | 0.66 | PF/DF | C57BL/6 J | α-syn KO | 0 | 1 | NA |
15 | Mus musculus | F | 0.66 | PF/DF | C57BL/6 J | WT | 1 | 1 | NA |
16 | Mus musculus | F | 0.66 | PF/DF | C57BL/6 J | WT | 1 | 1 | NA |
17 | Mus musculus | F | 0.66 | PF/DF | C57BL/6 J | WT | 1 | 1 | NA |
18 | Mus musculus | F | 0.66 | PF/DF | C57BL/6 J | WT | 1 | 1 | NA |
19 | Mus musculus | F | 0.66 | PF/DF | C57BL/6 J | WT | 1 | 1 | NA |
20 | Mus musculus | F | 0.83 | PF/DF | C57BL/6 J | WT | 1 | ND | NA |
21 | Mus musculus | F | 0.83 | PF/DF | C57BL/6 J | WT | 1 | ND | NA |
22 | Rattus norvegicus domestica | NK | 1.33 | DF | SD | WT | 0 | 1 | NA |
23 | Rattus norvegicus domestica | NK | 1.33 | DF | SD | WT | 1 | 1 | NA |
24 | Rattus norvegicus domestica | NK | 1.33 | DF | SD | WT | 1 | 1 | NA |
‡25 | Macaca fascicularis | M | 10.86 | PF/DF | NA | WT | 1 | 1 | NA |
26 | Macaca fascicularis | F | 5.59 | PF/DF | NA | WT | 1 | 1 | NA |
27 | Homo sapiens | F | 93.24 | DF | NA | NA | 0 | 0 | NS |
28 | Homo sapiens | M | 87.8 | DF | NA | NA | 0 | ND | NS |
29 | Homo sapiens | F | 74.1 | DF | NA | NA | 0 | 0 | NS |
30 | Homo sapiens | F | 87 | DF-Paraffin | NA | NA | 1 | 1 | NS |
31 | Homo sapiens | M | 69 | DF | NA | NA | 0 | 0 | PD/DLB |
32 | Homo sapiens | F | 70 | DF | NA | NA | 0 | 0 | PD/DLB |
33 | Homo sapiens | M | 86 | DF | NA | NA | 0 | 0 | PD/DLB |
34 | Homo sapiens | M | 81 | DF | NA | NA | 0 | 0 | PD/DLB |
35 | Homo sapiens | M | NK | DF | NA | NA | 0 | 0 | PD/DLB |
§36 | Homo sapiens | M | NK | DF | NA | NA | 1 | 1 | PD/DLB |
NA not assessed, NK not known, NS non-synucleinopathy, ND not determined, PF/DF perfusion fixation/drop fixation.
*Antibody EP1536Y was used to detect PSER129 in the OB. 0 means PSER129 positive cells were not observed in the mitral cell layer and 1 denotes PSER129 positive cells were observed in the mitral cell layer. Only staining conditions without proteinase K were considered.
†TBX21 is a mitral cell marker. 0 means no staining and 1 means staining.
‡Specimen 25 was euthanized early due to post-op-right subdural hematoma.
§Specimen 36 had weak TBX21 staining but was observed in the citrate retrieval condition.